SNAI2 and colorectal cancer: Despite limited published studies elucidating the underlying mechanism, recent in vitro experiments have revealed that treating HT29 colorectal cancer cell cultures with succinate results in the upregulation of the SUCNR1 receptor, as well as in the upregulation of mesenchymal markers such as SNAI1, SNAI2 and vimentin.